i






Public Title Status Last Date Modified
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium to High-dose Inhaled Corticosteroid Plus Long- . . . Ongoing 29 Jun 2020
Dose-finding, efficacy and safety of BI 655064 in patients with active lupus nephritis Completed 04 Mar 2021
A 24-week randomized, open-label Study to evaluate the Safety and Efficacy of Fesoterodine in Subjects aged 6 to 17 Years with Symptoms of Detrusor Overactivity associated with a neurological Conditio . . . Completed 14 Aug 2020
A Retrospective Comparison of Treatment Response between Short Course (6 months) and Extended Course (9 to 12 months) among Filipino Women with Genital Tract Tuberculosis who underwent Medical Managem . . . Completed 07 Jan 2021
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Seve . . . Ongoing 04 Sep 2020
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304) . . . Ongoing 19 Aug 2020
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) . . . Ongoing 10 Aug 2020
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) . . . Ongoing 10 Aug 2020
A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell . . . Ongoing 30 Sep 2020
A non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care in patient with chronic plaque psoriAsi . . . Completed 04 Jun 2020
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 Inactivated (Vero Cell) Vaccine in the Elderly 60-80 . . . Ongoing 10 Feb 2021
Anti-Coronavirus Therapies to prevent progression of COVID19 (ACT), a randomized trial Ongoing 30 Sep 2020
EFFECTIVENESS OF 100% TEA TREE OIL (Melaleuca alternifolia) VERSUS SALICYLIC ACID + LACTIC ACID SOLUTION IN THE TREATMENT OF COMMON WARTS: A RANDOMIZED CONTROL TRIAL . . . Pending 23 Feb 2021
Intravenous Tocilizumab in the Treatment of Patients with Severe and Critical COVID-19-related Pneumonia . . . Ongoing 05 Oct 2020
A 12-Month Open-Label Study to Evaluate the Safety and Tolerability of Pregabalin as Adjunctive Therapy in Pediatric Subjects 1 Month to 16 Years of Age with Partial Onset Seizures and Pediatric and A . . . Completed 17 Jul 2019
A 12-week phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of once monthly subcutaneous erenumab 70 mg in adult chronic migraine patients . . . Ongoing 07 Jan 2020
A 12-week, multicenter, randomized, double-blind, parallel-arm, placebo-controlled study to assess the efficacy and safety of CSJ117, when added to existing asthma therapy in patients ≥18 years of a . . . Pending 11 Dec 2020
A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthm . . . Completed 23 Apr 2020
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis . . . Ongoing 19 Aug 2019
A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS) . . . Ongoing 04 Jun 2020
A 24-week Treatment, Randomised, Parallel-group, Double blinded, Double- Dummy, Multicenter Study to Assess the Efficacy and Safety of Aclidinium bromide/Formoterol fumarate compared with Individual C . . . Completed 11 Mar 2020
A 46-week, Double-blind, Placebo-controlled, Phase 3 Study with a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis . . . Ongoing 12 Sep 2019
A 52-week, multicenter, randomized, double-blind, double dummy, parallel-group, placebo-controlled study of fevipiprant once daily plus standard-of-care (SoC) for reduction of systemic corticostero . . . Ongoing 23 Apr 2020
A 52-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma . . . Completed 23 Apr 2020
A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study comparing GSK3196165 with placebo and with tofacitinib, in combination with methotrexate in participants with moder . . . Ongoing 14 Aug 2020
©2021 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date